Smital Shah
Directeur/Bestuurslid bij PLIANT THERAPEUTICS, INC.
Vermogen: 12 978 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Smital Shah
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 24 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Smital Shah via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Founder | |
| University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
| HP INC. | Computer Processing Hardware | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | General Counsel Corporate Officer/Principal | |
| Drexel University College of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Charcot-Marie-Tooth Association
 Charcot-Marie-Tooth Association Miscellaneous Commercial ServicesCommercial Services The Charcot-Marie-Tooth Association operates as a non-profit organization. The private company is based in Glenolden, PA. Suzanne Louise Bruhn has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
| SANOFI | Biotechnology | Director/Board Member General Counsel | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| New York University | College/University | Graduate Degree Graduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Miscellaneous Commercial Services | Founder Chairman | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of the Witwatersrand | College/University | Doctorate Degree Doctorate Degree | |
| UCSF School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Cardiovascular Research Institute
 Cardiovascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Institute operates a cardiovascular research institute. The American company was founded by Alison Schecter. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member | |
| GERON CORPORATION | Biotechnology | Director/Board Member Chairman | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Private Equity Investor | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Nederland | 3 |
| België | 3 |
| Zwitserland | 2 |
| Mauritius (Eiland) | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 3 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 253 |
| Corporate Officer/Principal | 180 |
| Independent Dir/Board Member | 90 |
| Chief Tech/Sci/R&D Officer | 63 |
| Undergraduate Degree | 57 |
Sterkste connecties
| Insiders | |
|---|---|
| Henri A. Termeer | 42 |
| Neil Exter | 33 |
| Ho Young Huh | 32 |
| Charles Homcy | 28 |
| David Pyott | 27 |
| James Shannon | 22 |
| Gayle Crowell | 21 |
| James M. Denny | 19 |
| Suzanne Bruhn | 18 |
| Theresa Heggie | 16 |
| Darren Cline | 15 |
| Dennis D. Self | 14 |
| Derrell Porter | 14 |
| Roy Baynes | 13 |
| Eric Lefebvre | 13 |
- Beurs
- Insiders
- Smital Shah
- Bedrijfsconnecties
